ELAN FY 2021 Earnings — Elanco Animal Health Incorporated Revenue & Financial Results | Market Cap Arena

ELANElanco Animal Health Incorporated

$12B

FY 2021 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$4.8B+45.5% YoY

Gross Profit

$2.1B43.6% margin

Operating Income

$304M6.4% margin

Net Income

-$483M-10.1% margin

EPS (Diluted)

$-0.97

Cash Flow

Operating Cash Flow

$483M

Free Cash Flow

$286M

Stock-Based Comp.

$66M

Balance Sheet

Total Assets

$16.5B

Total Liabilities

$9.0B

Stockholders' Equity

$7.5B

Cash & Equivalents

$638M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$4.8B	$3.3B	+45.5%
Gross Profit	$2.1B	$1.2B	+66.5%
Operating Income	$304M	-$77M	+495.8%
Net Income	-$483M	-$560M	+13.8%